Darrell J Triulzi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Darrell J Triulzi

Showing results (151-160 of 160) with videos related to

Pageof 16

Sort By:

You have reached the last page of results.This site can display upto 160 results.

American Heart Journal|November 23, 2022

Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trialJeffrey L Carson, Maria Mori Brooks, Bernard R Chaitman, et al.

NEJM Evidence|December 23, 2024

Restrictive versus Liberal Transfusion in Myocardial Infarction - A Patient-Level Meta-AnalysisJeffrey L Carson, Dean A Fergusson, Helaine Noveck, et al.

The New England Journal of Medicine|February 19, 2010

Dose of prophylactic platelet transfusions and prevention of hemorrhageSherrill J Slichter, Richard M Kaufman, Susan F Assmann, et al.

The New England Journal of Medicine|August 18, 2021

Early Convalescent Plasma for High-Risk Outpatients with Covid-19Frederick K Korley, Valerie Durkalski-Mauldin, Sharon D Yeatts, et al.

The New England Journal of Medicine|July 26, 2018

Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic ShockJason L Sperry, Francis X Guyette, Joshua B Brown, et al.

Plos One|October 24, 2024

Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patientsCarlo J Iasella, Stefanie J Hannan, Emily J Lyons, et al.

American Journal of Respiratory and Critical Care Medicine|March 29, 2022

CD4<sup>+</sup> T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1-DependentIulia Popescu, Mark E Snyder, Carlo J Iasella, et al.

The New England Journal of Medicine|April 9, 2015

Effects of red-cell storage duration on patients undergoing cardiac surgeryMarie E Steiner, Paul M Ness, Susan F Assmann, et al.

The New England Journal of Medicine|November 12, 2023

Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and AnemiaJeffrey L Carson, Maria Mori Brooks, Paul C Hébert, et al.

JAMA|October 4, 2021

Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial, Lise J Estcourt, Alexis F Turgeon, et al.

Pageof 16

Search research articles

Showing results (151-160 of 160) with videos related to

Sort By:

Pageof 16

You have reached the last page of results.This site can display upto 160 results.

American Heart Journal|November 23, 2022

Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trialJeffrey L Carson, Maria Mori Brooks, Bernard R Chaitman, et al.

NEJM Evidence|December 23, 2024

Restrictive versus Liberal Transfusion in Myocardial Infarction - A Patient-Level Meta-AnalysisJeffrey L Carson, Dean A Fergusson, Helaine Noveck, et al.

The New England Journal of Medicine|February 19, 2010

Dose of prophylactic platelet transfusions and prevention of hemorrhageSherrill J Slichter, Richard M Kaufman, Susan F Assmann, et al.

The New England Journal of Medicine|August 18, 2021

Early Convalescent Plasma for High-Risk Outpatients with Covid-19Frederick K Korley, Valerie Durkalski-Mauldin, Sharon D Yeatts, et al.

The New England Journal of Medicine|July 26, 2018

Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic ShockJason L Sperry, Francis X Guyette, Joshua B Brown, et al.

Plos One|October 24, 2024

Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patientsCarlo J Iasella, Stefanie J Hannan, Emily J Lyons, et al.

American Journal of Respiratory and Critical Care Medicine|March 29, 2022

CD4<sup>+</sup> T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1-DependentIulia Popescu, Mark E Snyder, Carlo J Iasella, et al.

The New England Journal of Medicine|April 9, 2015

Effects of red-cell storage duration on patients undergoing cardiac surgeryMarie E Steiner, Paul M Ness, Susan F Assmann, et al.

The New England Journal of Medicine|November 12, 2023

Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and AnemiaJeffrey L Carson, Maria Mori Brooks, Paul C Hébert, et al.

JAMA|October 4, 2021

Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial, Lise J Estcourt, Alexis F Turgeon, et al.

Pageof 16